{"id":47030,"date":"2022-08-08T14:02:04","date_gmt":"2022-08-08T12:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/"},"modified":"2022-08-08T14:02:04","modified_gmt":"2022-08-08T12:02:04","slug":"thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/","title":{"rendered":"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit"},"content":{"rendered":"
\n

\nAssay helps detect drug resistant strains of HIV-1<\/i>\n<\/p>\n

CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretrovial therapeutics.\n<\/p>\n

<\/a><\/p>\n

\nHIV RNA extracted from EDTA plasma or dried blood spots is analyzed with the assay to measure genomic mutations in the protease, reverse transcriptase and integrase regions of the pol<\/i> gene. Data from these tests is intended to help inform global epidemiologic and genetic surveillance studies to track the ongoing evolution of the virus.\n<\/p>\n

\nThe kit is designed to support the detection of the UNAIDS 2030 95-95-95 HIV targets, which aims to have 95 percent of people living with HIV to be diagnosed, 95 percent who are diagnosed to be receiving treatment, and 95 percent of those on treatment to be virally suppressed. This enhanced research assay, which is compatible with the recently launched Applied Biosystems MagMAX Viral\/Pathogen Nucleic Acid Isolation Kit for HIV-1 Blood Spots, provides laboratories with a standardized tool for drug resistance surveillance of HIV mutations to antiretroviral therapeutic inhibitors which can help identify global areas of need.\n<\/p>\n

\n\u201cA key factor in identifying new public health treatment strategies is knowledge of the viral resistance genotypes present in a given population as indicated by mutations measured in that population,\u201d said Dr. Manoj Gandhi, senior medical director of genetic testing solutions at Thermo Fisher Scientific. \u201cMonitoring for treatment-resistant strains of HIV can improve global understanding of HIV and help keep the world\u2019s public health officials one step ahead of future developments.\u201d\n<\/p>\n

\nThe Applied Biosystems HIV-1 Genotyping Kit will analyze expanded targets associated with HIV drug resistance that include mutations in the integrase region of the pol<\/i> gene on Applied Biosystems Sanger sequencing CE instrumentation. It has been designed to offer broad Group M subtype coverage to address regions of the world with the greatest need such as Africa, Latin America, India and portions of Asia, where global health access pricing is available.\n<\/p>\n

\nFor more information on the HIVDR kit, please visit www.thermofisher.com\/hivdr<\/a>.\n<\/p>\n

\nFor research use only. Not for use in diagnostic procedures.\n<\/p>\n

\nAbout Thermo Fisher Scientific<\/b>\n<\/p>\n

\nThermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.\n<\/p>\n

\nFor more information, please visit www.thermofisher.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia\n<\/p>\n

\nMauricio Minotta
\n
Director, Public Relations
\n
Phone: +1 760-929-2456
\n
E-mail: mauricio.minotta@thermofisher.com<\/a>\n<\/p>\n

\nAriane Lovell
\n
FINN Partners
\n
Phone: +1 646-307-6317
\n
E-mail: ariane.lovell@finnpartners.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Assay helps detect drug resistant strains of HIV-1 CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretrovial therapeutics. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47030","6":"format-standard","7":"category-industry"},"yoast_head":"\nThermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Assay helps detect drug resistant strains of HIV-1 CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretrovial therapeutics. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-08T12:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220711005012\/en\/416828\/21\/TFS_logo_2c_tag_jpg.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit\",\"datePublished\":\"2022-08-08T12:02:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/\"},\"wordCount\":523,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005012\\\/en\\\/416828\\\/21\\\/TFS_logo_2c_tag_jpg.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/\",\"name\":\"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005012\\\/en\\\/416828\\\/21\\\/TFS_logo_2c_tag_jpg.jpg\",\"datePublished\":\"2022-08-08T12:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005012\\\/en\\\/416828\\\/21\\\/TFS_logo_2c_tag_jpg.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005012\\\/en\\\/416828\\\/21\\\/TFS_logo_2c_tag_jpg.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/","og_locale":"en_US","og_type":"article","og_title":"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit - Pharma Trend","og_description":"Assay helps detect drug resistant strains of HIV-1 CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretrovial therapeutics. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-08T12:02:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220711005012\/en\/416828\/21\/TFS_logo_2c_tag_jpg.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit","datePublished":"2022-08-08T12:02:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/"},"wordCount":523,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005012\/en\/416828\/21\/TFS_logo_2c_tag_jpg.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/","url":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/","name":"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005012\/en\/416828\/21\/TFS_logo_2c_tag_jpg.jpg","datePublished":"2022-08-08T12:02:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220711005012\/en\/416828\/21\/TFS_logo_2c_tag_jpg.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220711005012\/en\/416828\/21\/TFS_logo_2c_tag_jpg.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47030"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47030\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}